State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia—A Short Review and Diagnostic Algorithm

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Plasma Amyloid as Prescreener for the Earliest <scp>A</scp>lzheimer Pathological Changes2018 · 321 citations
2. 2Plasma and CSF neurofilament light2019 · 306 citations
3. 3Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease2018 · 269 citations
4. 4Comparison of Prodromal Symptoms of Patients with Behavioral Variant Frontotemporal Dementia and Alzheimer Disease2020 · 19 citations
5. 5Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome2017 · 273 citations